Genetics Pharmaceuticals company information, Employees & Contact Information

Opinion: How AI and Genetics Could Restore Public Trust in Pharma BioSpace

Primary Focus: Genetic Regulation Astellas

Trump's pharma import tariffs threaten drug pricing, generics TechTarget

Pharma giant Regeneron to buy genetics firm 23andMe for $256m Tech in Asia

Genetic breakthroughs could point pharma to a long COVID drug PharmaVoice

CVC Capital Partners to exit Italy’s Genetic pehub.com

In pharma JV, Pakistan to import Russian insulin The Express Tribune

Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers Fortune

Partnership in Genetics (Pharmaceutical) between Renaissance, Aurora and the Pavese family firstonline.info

CVC seeks €700mn for its Italian pharma outsourcer Genetic Financial Times

Segra International and GreenBe Pharma Forge a Partnership GlobeNewswire

CVC Capital Partners seeks cash injection for Italian pharma group Euronews.com

Microsoft and 1910 Genetics partner to turbocharge R&D productivity for the pharmaceutical industry Microsoft Azure

Why Pharma Should Pay Attention to – and Be Part of – Rapid Whole Genome Sequencing Advancement Fierce Pharma

Fulgent Genetics acquires therapeutics development firm Fulgent Pharma Pharmaceutical Technology

Next in pharma trends 2025 PwC

Ocuphire Pharma acquires Opus Genetics Modern Retina

CVC Strategic Opportunities II announces exit of Genetic Group cvc.com

Microsoft, 1910 Genetics eye biopharma breakthroughs drugdiscoverytrends.com

Rhythm Pharmaceuticals scores first FDA approval for obesity med targeting genetic defects Fierce Pharma

Why genetics makes drug development more reliable – and more human Nature

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics PR Newswire

Ocuphire Pharma just purchased Opus Genetics Eyes On Eyecare

Novo Nordisk explores a family tree to explain genetic roots of obesity in new social media clip Fierce Pharma

Ocuphire Pharma acquires Opus Genetics in all-stock transaction, to switch name Nasdaq

Regeneron in Deal to Acquire 23andMe for $256M Contract Pharma

Fulgent Genetics Reunites with Fulgent Pharma in $100M Acquisition Inside Precision Medicine

Vertex Pharmaceuticals Fierce Pharma

Ocuphire Pharma Announces Acquisition of Opus Genetics GlobeNewswire

Plasma proteomic associations with genetics and health in the UK Biobank Nature

Ocuphire and Opus Genetics merge to develop IRD gene therapy Pharmaceutical Technology

23andMe's Pharma Deals Have Been the Plan All Along WIRED

Biogen, PTC and more back BioMarin's genetic seizure testing effort for kids Fierce Pharma

NewLink Genetics and Lumos Pharma to Form Biopharma Company Investing News Network

Plotting a Fulgent future, diagnostic business inks $100M deal to reunite with drug delivery sibling Fierce Pharma

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger Genetic Engineering and Biotechnology News

Disease coverage of human genome-wide association studies and pharmaceutical research and development Nature

Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions New York Post

Sophia Genetics launches podcast to decode data- and AI-driven medical innovation Fierce Pharma

Genetics and genomics in medicine TechTarget

The Multimodal Imperative: How AI-Driven Technology is Driving Impactful Changes Fierce Pharma

Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Brazil Business Wire

BioMarin expands genetic seizure testing program for kids Fierce Pharma

SOPHiA Genetics and AstraZeneca Expand Ovarian Cancer Testing Program Contract Pharma

Seattle Genetics taps pharma oncology veteran as first-ever chief commercial officer Fierce Pharma

Ocuphire Pharma to transform into gene-therapy-focused biotech via Opus acquisition Fierce Biotech

Big Pharma Would Like Your DNA The Atlantic

Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021 Fierce Biotech

Lilly opens huge new Boston research center, with a focus on genetic medicines Endpoints News

Top 5 NASDAQ Genetics Stocks (Updated January 2025) Investing News Network

NB Renaissance Is Said to Near Deal for CVC-Backed Genetic Bloomberg.com

Seattle Genetics and Merck Partner Contract Pharma

Do large pharma companies provide drug development innovation? Our analysis says no statnews.com

NewLink’s two-decade run ends in reverse merger, layoffs BioPharma Dive

Merck pays Seattle Genetics $1.7B as antibody cancer drugs continue comeback BioPharma Dive

Seattle Genetics shortens name to Seagen, dropping local connection as it goes global Fierce Pharma

The Expanding Roles of Genetic Counselors in Specialty Pharmacy Management Pharmacy Times

GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research CNBC

Seattle Genetics, Astellas snag quick FDA approval for bladder cancer fighter Padcev Fierce Pharma

HAYA Therapeutics Appoints Cardiology and Genetics Medicines Expert Jordan Shin, M.D., Ph.D. as Chief Medical Officer Business Wire

Merck's Seattle Genetics ADC deal extends blockbuster Keytruda franchise: analyst Fierce Pharma

In transition and tumult, Seagen names former Novartis oncology chief Epstein as new CEO Fierce Pharma

UPDATED: Seagen CEO Clay Siegall put on leave after domestic violence arrest Fierce Pharma

In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off Fierce Pharma

New Astellas, Seattle Genetics Padcev combo data spark $5.8B sales hopes Fierce Pharma

Seattle Genetics investors breathe a sigh of relief as Adcetris posts 30% sales growth Fierce Pharma

A Major Drug Company Now Has Access to 23andMe’s Genetic Data. Should You Be Concerned? Time Magazine

Genomic sciences GSK

Seattle Genetics, Astellas' bladder cancer med Padcev blows early expectations out of the water Fierce Pharma

Astellas, Seattle Genetics' Padcev bladder cancer trial stops early with 30% death risk reduction Fierce Pharma

Seattle Genetics CEO goes inside its lightning-quick Adcetris nod, courtesy of FDA's real-time pilot Fierce Pharma

Genetic testing: Opportunities to unlock value in precision medicine McKinsey & Company

Pakistan to import insulin from Russia through pharmaceutical joint ventures Profit by Pakistan Today